Theon International Plc (THEON) has entered into a definitive agreement with HLD Europe SCA, Invest Prince Henri SCA and Invest Gamma Sarl, investment companies belonging to Groupe HLD, to purchase a 9.8% stake in Exosens SA (EXOSENS) for a cash consideration of €268.7 million.
EXOSENS is a leading French company specializing in advanced electro-optical technologies, including light amplification, detection and imaging systems. Following the completion of the transaction, THEON will become the second largest shareholder in EXOSENS, after Groupe HLD.
The closing of the transaction remains subject to regulatory notifications in a selected number of countries, and is expected to take place in early Q1 2026.
The Clifford Chance corporate team was composed in Paris of Gilles Lebreton and Aline Cardin, partners, and Katerina Drakoularakou, counsel, as well as in Frankfurt of George Hacket, partner, and Andrei Manea, counsel.
David Tayar, partner, Hendrik Coppoolse and Marlen Pezzetta, associates, also advised on the antitrust and FDI aspects.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.
Lawyers and firms: get featured on Legal Desire
Share your deals, lateral moves, firm news and insights with 1M+ monthly readers: founders, law firm partners, general counsel and practising lawyers across the US, UK, EU and GCC.
Get featuredSubmit a press releaseThe advising firms, the named deal team, the value and the parties, with every other announced deal by the same firms and lawyers. Open the deal record
